APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ketorolac Tromethamine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ketorolac Tromethamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchKetorolac Tromethamine Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Ketorolac Tromethamine Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Ketorolac Tromethamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ketorolac Tromethamine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Ketorolac Tromethamine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Ketorolac Tromethamine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Ketorolac Tromethamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ketorolac Tromethamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ketorolac Tromethamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ketorolac Tromethamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ketorolac Tromethamine include Teva, Sun Pharmaceutical, Sandoz, Mylan, Pfizer, Sagent Pharmaceuticals, Omeros Corporation, Gland Pharma Limited and Egalet US Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ketorolac Tromethamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ketorolac Tromethamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ketorolac Tromethamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ketorolac Tromethamine market size, projected growth trends, production technologies, key applications, and end-use industries.

Ketorolac Tromethamine Segment by Company

Teva

Sun Pharmaceutical

Sandoz

Mylan

Pfizer

Sagent Pharmaceuticals

Omeros Corporation

Gland Pharma Limited

Egalet US Inc.

Dr. Reddy’s Laboratories

Aurobindo Pharma

Apotex

Amphastar Pharmaceuticals

Allergan

Akorn

Ketorolac Tromethamine Segment by Type

Nasal

Oral tablet

Ophthalmic

Injection

Ketorolac Tromethamine Segment by Application

Hospital

Clinic

Others

Ketorolac Tromethamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketorolac Tromethamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ketorolac Tromethamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketorolac Tromethamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ketorolac Tromethamine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ketorolac Tromethamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ketorolac Tromethamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Ketorolac Tromethamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Ketorolac Tromethamine Industry Trends Table 2. Ketorolac Tromethamine Industry Drivers Table 3. Ketorolac Tromethamine Industry Opportunities and Challenges Table 4. Ketorolac Tromethamine Industry Restraints Table 5. Global Ketorolac Tromethamine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Ketorolac Tromethamine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Ketorolac Tromethamine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Ketorolac Tromethamine Sales Market Share by Manufacturers Table 9. Global Ketorolac Tromethamine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Ketorolac Tromethamine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Ketorolac Tromethamine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Ketorolac Tromethamine Manufacturers, Product Type & Application Table 13. Global Ketorolac Tromethamine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Ketorolac Tromethamine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Nasal Table 17. Major Manufacturers of Oral tablet Table 18. Major Manufacturers of Ophthalmic Table 19. Major Manufacturers of Injection Table 20. Global Ketorolac Tromethamine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Ketorolac Tromethamine Sales by Type (2021-2026) & (k units) Table 22. Global Ketorolac Tromethamine Sales by Type (2027-2032) & (k units) Table 23. Global Ketorolac Tromethamine Sales Market Share by Type (2021-2026) Table 24. Global Ketorolac Tromethamine Sales Market Share by Type (2027-2032) Table 25. Global Ketorolac Tromethamine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Ketorolac Tromethamine Revenue by Type (2021-2026) & (k units) Table 27. Global Ketorolac Tromethamine Revenue by Type (2027-2032) & (k units) Table 28. Global Ketorolac Tromethamine Revenue Market Share by Type (2021-2026) Table 29. Global Ketorolac Tromethamine Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Others Table 33. Global Ketorolac Tromethamine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Ketorolac Tromethamine Sales by Application (2021-2026) & (k units) Table 35. Global Ketorolac Tromethamine Sales by Application (2027-2032) & (k units) Table 36. Global Ketorolac Tromethamine Sales Market Share by Application (2021-2026) Table 37. Global Ketorolac Tromethamine Sales Market Share by Application (2027-2032) Table 38. Global Ketorolac Tromethamine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Ketorolac Tromethamine Revenue by Application (2021-2026) & (k units) Table 40. Global Ketorolac Tromethamine Revenue by Application (2027-2032) & (k units) Table 41. Global Ketorolac Tromethamine Revenue Market Share by Application (2021-2026) Table 42. Global Ketorolac Tromethamine Revenue Market Share by Application (2027-2032) Table 43. Global Ketorolac Tromethamine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Ketorolac Tromethamine Sales by Region (2021-2026) & (k units) Table 45. Global Ketorolac Tromethamine Sales Market Share by Region (2021-2026) Table 46. Global Ketorolac Tromethamine Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Ketorolac Tromethamine Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Ketorolac Tromethamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Ketorolac Tromethamine Sales by Country (2021-2026) & (k units) Table 50. North America Ketorolac Tromethamine Sales by Country (2027-2032) & (k units) Table 51. Europe Ketorolac Tromethamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Ketorolac Tromethamine Sales by Country (2021-2026) & (k units) Table 53. Europe Ketorolac Tromethamine Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Ketorolac Tromethamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Ketorolac Tromethamine Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Ketorolac Tromethamine Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Ketorolac Tromethamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Ketorolac Tromethamine Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Ketorolac Tromethamine Sales by Country (2027-2032) & (k units) Table 60. Global Ketorolac Tromethamine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Ketorolac Tromethamine Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Ketorolac Tromethamine Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Ketorolac Tromethamine Revenue Market Share by Region (2021-2026) Table 64. Global Ketorolac Tromethamine Revenue Market Share by Region (2027-2032) Table 65. Teva Company Information Table 66. Teva Business Overview Table 67. Teva Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Teva Ketorolac Tromethamine Product Portfolio Table 69. Teva Recent Development Table 70. Sun Pharmaceutical Company Information Table 71. Sun Pharmaceutical Business Overview Table 72. Sun Pharmaceutical Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Sun Pharmaceutical Ketorolac Tromethamine Product Portfolio Table 74. Sun Pharmaceutical Recent Development Table 75. Sandoz Company Information Table 76. Sandoz Business Overview Table 77. Sandoz Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sandoz Ketorolac Tromethamine Product Portfolio Table 79. Sandoz Recent Development Table 80. Mylan Company Information Table 81. Mylan Business Overview Table 82. Mylan Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Mylan Ketorolac Tromethamine Product Portfolio Table 84. Mylan Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Pfizer Ketorolac Tromethamine Product Portfolio Table 89. Pfizer Recent Development Table 90. Sagent Pharmaceuticals Company Information Table 91. Sagent Pharmaceuticals Business Overview Table 92. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Sagent Pharmaceuticals Ketorolac Tromethamine Product Portfolio Table 94. Sagent Pharmaceuticals Recent Development Table 95. Omeros Corporation Company Information Table 96. Omeros Corporation Business Overview Table 97. Omeros Corporation Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Omeros Corporation Ketorolac Tromethamine Product Portfolio Table 99. Omeros Corporation Recent Development Table 100. Gland Pharma Limited Company Information Table 101. Gland Pharma Limited Business Overview Table 102. Gland Pharma Limited Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Gland Pharma Limited Ketorolac Tromethamine Product Portfolio Table 104. Gland Pharma Limited Recent Development Table 105. Egalet US Inc. Company Information Table 106. Egalet US Inc. Business Overview Table 107. Egalet US Inc. Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Egalet US Inc. Ketorolac Tromethamine Product Portfolio Table 109. Egalet US Inc. Recent Development Table 110. Dr. Reddy’s Laboratories Company Information Table 111. Dr. Reddy’s Laboratories Business Overview Table 112. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Portfolio Table 114. Dr. Reddy’s Laboratories Recent Development Table 115. Aurobindo Pharma Company Information Table 116. Aurobindo Pharma Business Overview Table 117. Aurobindo Pharma Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Aurobindo Pharma Ketorolac Tromethamine Product Portfolio Table 119. Aurobindo Pharma Recent Development Table 120. Apotex Company Information Table 121. Apotex Business Overview Table 122. Apotex Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Apotex Ketorolac Tromethamine Product Portfolio Table 124. Apotex Recent Development Table 125. Amphastar Pharmaceuticals Company Information Table 126. Amphastar Pharmaceuticals Business Overview Table 127. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Amphastar Pharmaceuticals Ketorolac Tromethamine Product Portfolio Table 129. Amphastar Pharmaceuticals Recent Development Table 130. Allergan Company Information Table 131. Allergan Business Overview Table 132. Allergan Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Allergan Ketorolac Tromethamine Product Portfolio Table 134. Allergan Recent Development Table 135. Akorn Company Information Table 136. Akorn Business Overview Table 137. Akorn Ketorolac Tromethamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Akorn Ketorolac Tromethamine Product Portfolio Table 139. Akorn Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Ketorolac Tromethamine Distributors List Table 143. Ketorolac Tromethamine Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Ketorolac Tromethamine Product Image Figure 2. Global Ketorolac Tromethamine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ketorolac Tromethamine Market Size (2021-2032) & (US$ Million) Figure 4. Global Ketorolac Tromethamine Sales (2021-2032) & (k units) Figure 5. Global Ketorolac Tromethamine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Ketorolac Tromethamine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Nasal Image Figure 9. Oral tablet Image Figure 10. Ophthalmic Image Figure 11. Injection Image Figure 12. Global Ketorolac Tromethamine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Ketorolac Tromethamine Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Ketorolac Tromethamine Sales Market Share by Type (2021-2032) Figure 15. Global Ketorolac Tromethamine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Ketorolac Tromethamine Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Ketorolac Tromethamine Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Ketorolac Tromethamine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Ketorolac Tromethamine Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Ketorolac Tromethamine Sales Market Share by Application (2021-2032) Figure 24. Global Ketorolac Tromethamine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Ketorolac Tromethamine Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Ketorolac Tromethamine Revenue Market Share by Application (2021-2032) Figure 27. North America Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Ketorolac Tromethamine Sales Market Share by Country (2021-2032) Figure 29. U.S. Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Ketorolac Tromethamine Sales Market Share by Country (2021-2032) Figure 34. Germany Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Ketorolac Tromethamine Sales Market Share by Country (2021-2032) Figure 41. China Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Ketorolac Tromethamine Sales Market Share by Country (2021-2032) Figure 49. Brazil Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Ketorolac Tromethamine Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Ketorolac Tromethamine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Ketorolac Tromethamine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Figure 60. North America Ketorolac Tromethamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Figure 62. Europe Ketorolac Tromethamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Ketorolac Tromethamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Ketorolac Tromethamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Ketorolac Tromethamine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Ketorolac Tromethamine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal
  • Oral tablet
  • Ophthalmic
  • Injection
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Sandoz
  • Mylan
  • Pfizer
  • Sagent Pharmaceuticals
  • Omeros Corporation
  • Gland Pharma Limited
  • Egalet US Inc.
  • Dr. Reddy’s Laboratories
  • Aurobindo Pharma
  • Apotex
  • Amphastar Pharmaceuticals
  • Allergan
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ketorolac Tromethamine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ketorolac Tromethamine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Ketorolac Tromethamine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Ketorolac Tromethamine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Ketorolac Tromethamine Market Dynamics
  1. 2.1 Ketorolac Tromethamine Industry Trends
  2. 2.2 Ketorolac Tromethamine Industry Drivers
  3. 2.3 Ketorolac Tromethamine Industry Opportunities and Challenges
  4. 2.4 Ketorolac Tromethamine Industry Restraints
3 Ketorolac Tromethamine Market by Manufacturers
  1. 3.1 Global Ketorolac Tromethamine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Ketorolac Tromethamine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Ketorolac Tromethamine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Ketorolac Tromethamine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ketorolac Tromethamine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Ketorolac Tromethamine Manufacturers, Product Type & Application
  7. 3.7 Global Ketorolac Tromethamine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ketorolac Tromethamine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ketorolac Tromethamine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ketorolac Tromethamine Tier 1, Tier 2, and Tier 3
4 Ketorolac Tromethamine Market by Type
  1. 4.1 Ketorolac Tromethamine Type Introduction
  2. 4.1.1 Nasal
  3. 4.1.2 Oral tablet
  4. 4.1.3 Ophthalmic
  5. 4.1.4 Injection
  6. 4.2 Global Ketorolac Tromethamine Sales by Type
  7. 4.2.1 Global Ketorolac Tromethamine Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Ketorolac Tromethamine Sales by Type (2021-2032)
  9. 4.2.3 Global Ketorolac Tromethamine Sales Market Share by Type (2021-2032)
  10. 4.3 Global Ketorolac Tromethamine Revenue by Type
  11. 4.3.1 Global Ketorolac Tromethamine Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Ketorolac Tromethamine Revenue by Type (2021-2032)
  13. 4.3.3 Global Ketorolac Tromethamine Revenue Market Share by Type (2021-2032)
5 Ketorolac Tromethamine Market by Application
  1. 5.1 Ketorolac Tromethamine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Ketorolac Tromethamine Sales by Application
  6. 5.2.1 Global Ketorolac Tromethamine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ketorolac Tromethamine Sales by Application (2021-2032)
  8. 5.2.3 Global Ketorolac Tromethamine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Ketorolac Tromethamine Revenue by Application
  10. 5.3.1 Global Ketorolac Tromethamine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ketorolac Tromethamine Revenue by Application (2021-2032)
  12. 5.3.3 Global Ketorolac Tromethamine Revenue Market Share by Application (2021-2032)
6 Global Ketorolac Tromethamine Sales by Region
  1. 6.1 Global Ketorolac Tromethamine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ketorolac Tromethamine Sales by Region (2021-2032)
  3. 6.2.1 Global Ketorolac Tromethamine Sales by Region (2021-2026)
  4. 6.2.2 Global Ketorolac Tromethamine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ketorolac Tromethamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Ketorolac Tromethamine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Ketorolac Tromethamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Ketorolac Tromethamine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Ketorolac Tromethamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Ketorolac Tromethamine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Ketorolac Tromethamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Ketorolac Tromethamine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Ketorolac Tromethamine Revenue by Region
  1. 7.1 Global Ketorolac Tromethamine Revenue by Region
  2. 7.1.1 Global Ketorolac Tromethamine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Ketorolac Tromethamine Revenue by Region (2021-2026)
  4. 7.1.3 Global Ketorolac Tromethamine Revenue by Region (2027-2032)
  5. 7.1.4 Global Ketorolac Tromethamine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Ketorolac Tromethamine Revenue (2021-2032)
  8. 7.2.2 North America Ketorolac Tromethamine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Ketorolac Tromethamine Revenue (2021-2032)
  11. 7.3.2 Europe Ketorolac Tromethamine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Ketorolac Tromethamine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Ketorolac Tromethamine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Ketorolac Tromethamine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Ketorolac Tromethamine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Ketorolac Tromethamine Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sun Pharmaceutical
  8. 8.2.1 Sun Pharmaceutical Company Information
  9. 8.2.2 Sun Pharmaceutical Business Overview
  10. 8.2.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Ketorolac Tromethamine Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Ketorolac Tromethamine Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Ketorolac Tromethamine Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Ketorolac Tromethamine Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Sagent Pharmaceuticals
  32. 8.6.1 Sagent Pharmaceuticals Company Information
  33. 8.6.2 Sagent Pharmaceuticals Business Overview
  34. 8.6.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sagent Pharmaceuticals Ketorolac Tromethamine Product Portfolio
  36. 8.6.5 Sagent Pharmaceuticals Recent Developments
  37. 8.7 Omeros Corporation
  38. 8.7.1 Omeros Corporation Company Information
  39. 8.7.2 Omeros Corporation Business Overview
  40. 8.7.3 Omeros Corporation Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Omeros Corporation Ketorolac Tromethamine Product Portfolio
  42. 8.7.5 Omeros Corporation Recent Developments
  43. 8.8 Gland Pharma Limited
  44. 8.8.1 Gland Pharma Limited Company Information
  45. 8.8.2 Gland Pharma Limited Business Overview
  46. 8.8.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Gland Pharma Limited Ketorolac Tromethamine Product Portfolio
  48. 8.8.5 Gland Pharma Limited Recent Developments
  49. 8.9 Egalet US Inc.
  50. 8.9.1 Egalet US Inc. Company Information
  51. 8.9.2 Egalet US Inc. Business Overview
  52. 8.9.3 Egalet US Inc. Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Egalet US Inc. Ketorolac Tromethamine Product Portfolio
  54. 8.9.5 Egalet US Inc. Recent Developments
  55. 8.10 Dr. Reddy’s Laboratories
  56. 8.10.1 Dr. Reddy’s Laboratories Company Information
  57. 8.10.2 Dr. Reddy’s Laboratories Business Overview
  58. 8.10.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Portfolio
  60. 8.10.5 Dr. Reddy’s Laboratories Recent Developments
  61. 8.11 Aurobindo Pharma
  62. 8.11.1 Aurobindo Pharma Company Information
  63. 8.11.2 Aurobindo Pharma Business Overview
  64. 8.11.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Aurobindo Pharma Ketorolac Tromethamine Product Portfolio
  66. 8.11.5 Aurobindo Pharma Recent Developments
  67. 8.12 Apotex
  68. 8.12.1 Apotex Company Information
  69. 8.12.2 Apotex Business Overview
  70. 8.12.3 Apotex Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Apotex Ketorolac Tromethamine Product Portfolio
  72. 8.12.5 Apotex Recent Developments
  73. 8.13 Amphastar Pharmaceuticals
  74. 8.13.1 Amphastar Pharmaceuticals Company Information
  75. 8.13.2 Amphastar Pharmaceuticals Business Overview
  76. 8.13.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Amphastar Pharmaceuticals Ketorolac Tromethamine Product Portfolio
  78. 8.13.5 Amphastar Pharmaceuticals Recent Developments
  79. 8.14 Allergan
  80. 8.14.1 Allergan Company Information
  81. 8.14.2 Allergan Business Overview
  82. 8.14.3 Allergan Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Allergan Ketorolac Tromethamine Product Portfolio
  84. 8.14.5 Allergan Recent Developments
  85. 8.15 Akorn
  86. 8.15.1 Akorn Company Information
  87. 8.15.2 Akorn Business Overview
  88. 8.15.3 Akorn Ketorolac Tromethamine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Akorn Ketorolac Tromethamine Product Portfolio
  90. 8.15.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ketorolac Tromethamine Value Chain Analysis
  2. 9.1.1 Ketorolac Tromethamine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ketorolac Tromethamine Production Mode & Process
  6. 9.2 Ketorolac Tromethamine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ketorolac Tromethamine Distributors
  9. 9.2.3 Ketorolac Tromethamine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst